PT  - JOURNAL ARTICLE
AU  - Wale, Alesha
AU  - Okolie, Chukwudi
AU  - Everitt, Jordan
AU  - Hookway, Amy
AU  - Shaw, Hannah
AU  - Little, Kirsty
AU  - Lewis, Ruth
AU  - Cooper, Alison
AU  - Edwards, Adrian
TI  - A rapid evidence map of what evidence is available on the effectiveness of community diagnostic centres
AID  - 10.1101/2022.12.01.22282959
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.12.01.22282959
4099  - http://medrxiv.org/content/early/2022/12/06/2022.12.01.22282959.short
4100  - http://medrxiv.org/content/early/2022/12/06/2022.12.01.22282959.full
AB  - The COVID-19 pandemic has resulted in increased demand and delays to diagnostic services. Community diagnostic centres (which are generally referred to as Regional Diagnostic Hubs in Wales) aim to reduce this backlog and the waiting times for patients by providing a broad range of elective diagnostic services in the community, away from acute hospital facilities. As diagnostic services account for over 85% of clinical pathways and cost the National Health Service (NHS) over six billion pounds a year (NHS 2022), community diagnostic centres across a broader range of diagnostic services may be an effective, efficient, and cost-effective introduction to the UK health sector. This Rapid Evidence Map aimed to identify, describe, and map the available evidence on the effectiveness of diagnostic centres. 50 primary studies were identified. Studies were published between 1995 and 2021: A wide range of study designs were used, and studies were conducted in a range of countries including the UK. 30 studies were specific to cancer diagnosis, whilst the remaining 20 studies focused on diagnosis associated with: anaemia, autism, cerebral palsy, intellectual disability, multiple sclerosis, respiratory conditions, shoulder pain, and unexplained fever Eleven studies reported information on multi-condition diagnostic centres, rather than a specific condition.The majority of studies were conducted within hospital settings. Two studies evaluated diagnostic centres within a community setting. The diagnostic centres offered a wide range of diagnostic tests and incorporated different staff and facilities. Participants were mainly referred by GPs, primary care centres and emergency departments. However, referrals were also made from outpatient clinics located within the same hospital as the diagnostic centre.Over 100 different outcomes were reported covering: patient data and referral outcomes, clinical outcomes, performance outcomes, economic outcomes, and patient and physician-reported outcomes.The findings of this rapid evidence map were used to select a substantive focus for a subsequent rapid review on community diagnostic centres that can be accessed by primary care teams.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPublic Health Wales was funded for this work by the Wales COVID-19 Evidence Centre, itself funded by Health & Care Research Wales on behalf of Welsh GovernmentAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsAcronymFull DescriptionCDCComplex Diagnostic ClinicCMVCytomegalovirusCOVID-19Coronavirus Disease 2019CTComputed TomographyDDCDemyelinating Disease Diagnostic ClinicEBVEpstein–Barr virusEDEmergency DepartmentERCPEndoscopic Retrograde CholangiopancreatographyFNPAFine-Needle Puncture AspirationFUNFever of Uncertain NatureGNCGeneral Neurology ClinicGPGeneral PractitionerHIVHuman Immunodeficiency VirusIIUInpatient Investigation UnitMRIMagnetic Resonance ImagingNHSNational Health ServicePCCPrimary Care CentresPET-CTPositron Emission Tomography-Computed TomographyPHCPrimary HealthcareREMRapid Evidence MapRRRapid ReviewRCTRandomised Controlled TrialQDUQuick Diagnosis UnitTACTechnical Advisory CellUKUnited KingdomWCECWelsh Covid-19 Evidence Centre